Analysts expect The Cooper Companies, Inc. (NYSE:COO – Get Rating) to post earnings per share of $3.45 for the current fiscal quarter, according to Zacks. Seven analysts have provided estimates for Cooper Companies’ earnings, with the highest EPS estimate coming in at $3.51 and the lowest estimate coming in at $3.41. Cooper Companies posted earnings of $3.38 per share during the same quarter last year, which would indicate a positive year over year growth rate of 2.1%. The firm is scheduled to announce its next earnings report after the market closes on Monday, January 1st.
According to Zacks, analysts expect that Cooper Companies will report full-year earnings of $14.09 per share for the current financial year, with EPS estimates ranging from $13.90 to $14.45. For the next financial year, analysts expect that the business will report earnings of $15.97 per share, with EPS estimates ranging from $15.50 to $16.39. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of research analysts that follow Cooper Companies.
Cooper Companies (NYSE:COO – Get Rating) last posted its quarterly earnings data on Thursday, March 3rd. The medical device company reported $3.24 earnings per share for the quarter, topping the consensus estimate of $3.10 by $0.14. The firm had revenue of $787.20 million for the quarter, compared to analysts’ expectations of $739.30 million. Cooper Companies had a return on equity of 9.89% and a net margin of 31.00%. The company’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same quarter last year, the business earned $3.17 EPS.
COO opened at $341.21 on Friday. The firm has a market cap of $16.82 billion, a P/E ratio of 18.10, a price-to-earnings-growth ratio of 2.19 and a beta of 0.90. Cooper Companies has a 52-week low of $309.43 and a 52-week high of $463.59. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.67 and a current ratio of 1.02. The business’s fifty day moving average is $386.07 and its 200-day moving average is $396.99.
In other Cooper Companies news, Director Jody S. Lindell sold 700 shares of the stock in a transaction on Monday, April 4th. The stock was sold at an average price of $421.04, for a total transaction of $294,728.00. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Agostino Ricupati sold 5,607 shares of the stock in a transaction on Friday, March 18th. The shares were sold at an average price of $421.51, for a total value of $2,363,406.57. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 19,646 shares of company stock valued at $8,195,614. 1.70% of the stock is owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the company. Sawtooth Solutions LLC purchased a new position in shares of Cooper Companies in the 1st quarter worth $236,000. The Manufacturers Life Insurance Company boosted its stake in shares of Cooper Companies by 5.5% in the 1st quarter. The Manufacturers Life Insurance Company now owns 230,227 shares of the medical device company’s stock worth $96,183,000 after buying an additional 11,966 shares during the last quarter. Toroso Investments LLC boosted its stake in shares of Cooper Companies by 12.3% in the 1st quarter. Toroso Investments LLC now owns 1,189 shares of the medical device company’s stock worth $497,000 after buying an additional 130 shares during the last quarter. Orion Portfolio Solutions LLC boosted its stake in shares of Cooper Companies by 6.4% in the 1st quarter. Orion Portfolio Solutions LLC now owns 1,063 shares of the medical device company’s stock worth $444,000 after buying an additional 64 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its stake in shares of Cooper Companies by 55.9% in the 1st quarter. BNP Paribas Arbitrage SA now owns 20,006 shares of the medical device company’s stock worth $8,354,000 after buying an additional 7,173 shares during the last quarter. Hedge funds and other institutional investors own 98.38% of the company’s stock.
Cooper Companies Company Profile (Get Rating)
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
- Get a free copy of the StockNews.com research report on Cooper Companies (COO)
- MarketBeat: Week in Review 5/16 – 5/20
- 3 Retailers That Defied First Quarter Headwinds
- Rapid7: Could Be Profitable in FY 2022 Despite Bear Market
- Will John Deere’s Earnings Help to Calm the Markets?
- Lowe’s Companies Has Not Bottomed
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.